R

RemeGen
9995

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$35.93B
EV
HK$38.09B
Shares Outstanding
555.84M
Beta
0.67

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
HK$33.50
P/E 2025E
-
P/Revenue 2025E
14.04x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About RemeGen Co., Ltd.

gainify

R

RemeGen Co., Ltd.

9995

RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company o...

Sector

Healthcare

Industry

Biotechnology

CEO

Fang, Jianmin

Employees

2,999

IPO Date

2020-11-09

Headquarters

58 Middle Beijing Road, Yantai Development Zone, Yantai Area of Shandong Pilot Free Trade, Yantai, Shandong Province China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.